Value Investors: 1 Health and Wellness Giant to Own Forever

Neptune Wellness Solutions (TSX:NEPT)(NASDAQ:NEPT) has demonstrated a clear intent to maximize the company’s return on investment.

| More on:
Dad and son having fun outdoor. Healthy living concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Neptune Wellness (TSX:NEPT)(NASDAQ:NEPT) is a diversified and fully integrated health and wellness company. Through the company’s flagship consumer-facing brands, Neptune has built a broad portfolio of natural, plant-based, sustainable and purpose-driven lifestyle brands and consumer packaged goods products in key health and wellness markets, including hemp, nutraceuticals, personal care and home care. Neptune’s corporate headquarters is located in Laval, Quebec. The company owns a 50,000-square-foot production facility located in Sherbrooke, Quebec and a 24,000 square-foot facility located in North Carolina.

Cost-efficient supply chain infrastructure

Leveraging decades of expertise in extraction and specialty ingredient formulation, Neptune is a leading provider of turnkey product development and supply chain solutions to businesses and government customers across several health and wellness verticals. The company utilizes a highly flexible and cost-efficient supply chain infrastructure that can be scaled up and down or into adjacent product categories to quickly adapt to market demand.

Neptune’s vision is to provide wellness solutions that deliver optimal health and wellness. The company leverages Neptune’s scientific and technological expertise to create and provide global customers with the best available products and wellness solutions. In 2019, the company received a standard processing license from Health Canada, which allowed Neptune to process and sell cannabis and to pursue cannabis-related activities.

Differentiated product offerings

Recently, Neptune developed a novel cold ethanol extraction technology which, when combined with the high level of automation at the company’s Sherbrooke facility, should position it as a cost-efficient cannabinoid (CBD) extractor in Canada. The technology supports differentiated product offerings through the company’s various delivery systems, colours and branding possibilities. Furthermore, it is an effective technology for variable and multiple product formulation runs.

In February 2020, Neptune launched two brands called Forest Remedies and Ocean Remedies. Under the Forest Remedies brand, Neptune intends to commercialize a full line of health and wellness products with and without CBD. The initial launch of the Forest Remedies brand is expected to be focused in the United States and may expand to Canada once Neptune obtains a license amendment from Health Canada to include the authorization to sell cannabis products. This will ensure that Neptune is able to sell the Forest Remedies brand at retailers across the United States.

Demonstrated agility

Most recently, in April 2020, Neptune expanded into the production and sale of hand sanitizer products. Neptune decided to use the company’s facilities in Sherbrooke, Quebec and Conover, North Carolina and third-party manufacturers to produce and sell hand sanitizer gel products at retail and wholesale.

Additionally, in May 2020, Neptune announced the launch of Neptune Air, a non-contact infrared thermometer optimized for measuring a person’s temperature while reducing cross-contamination risk and thereby minimizing the risk of spreading disease.

The expansion of Neptune’s product portfolio with products, including hand sanitizers and non-contact thermometers was a strategic response to COVID-19. Based on Neptune’s expected growth rate and planned investment in the company’s equipment and facilities, management believes that the company’s manufacturing capacity will be sufficient to meet requirements for the near future. The company has demonstrated a clear intention is to maximize the return on investment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »